Document is current
Any future updates will be listed below
-
Authors
Kaneda, Toshihiko
Kurata, Takayasu
Yoshida, Tomoko
Kibata, Kayoko
Yoshioka, Hiroshige
Yanagimoto, Hiroaki
Takeda, Kazuhiko
Yoshida, Takao
Tsuta, Koji
- License Information
-
More Information
Article History
Received: 31 October 2021
Accepted: 28 January 2022
First Online: 8 February 2022
Declarations
:
: All methods were conducted in accordance with the Declaration of Helsinki and Japanese regulations. This study protocol was approved by the Institutional Review Board (IRB) of Kansai Medical University Hospital (approval number: 2018051). Informed consent to participate in the study was obtained from subjects by opt-out style.
: Not applicable.
: TK received personal fees from AstraZeneca, Boehringer Ingelheim, Bristol Myeres, Chugai, Eli Lilly, MSD, and Ono Pharmaceutical Co., Ltd. Kurata T received grants from AstraZeneca, Eli Lilly, MSD, Ono Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Company, outside the submitted work. KT received personal fees from AstraZeneca, Janssen Pharmaceutical K.K., MSD, Novartis, and Roche. TY, KT, and TY are paid employees of Ono Pharmaceutical Co., Ltd. Other authors have no conflicts of interest to declare.
